Clinic of Neurosurgery, University Clinics Schleswig, Holstein Campus Kiel Arnold-Heller str. 3, 24105, Germany.
Clinic of Neurosurgery, University Clinics Schleswig, Holstein Campus Kiel Arnold-Heller str. 3, 24105, Germany.
Am J Emerg Med. 2019 Nov;37(11):2079-2083. doi: 10.1016/j.ajem.2019.03.001. Epub 2019 Mar 10.
Patients suffering from aneurysmatic Subarachnoid Hemorrhage (SAH) may present with a variety of symptoms. The aim of this study is to evaluate the spectrum of misdiagnoses and to analyze the significance of delay of correct diagnosis on the clinical outcome.
The data was collected prospectively from 2003 to 2013. Patients diagnosed with disease different from aneurysmal SAH by the initially treating physician, and admitted to our department with a delay of at least 24 h after the beginning of the symptoms, were included in this study. We analyzed the various diagnoses that were ascertained instead of SAH and which medical specialty had provided them.
Overall 704 patients were treated with acute SAH. The inclusion criteria were matched in 76 patients (13.7%). Eleven specialties were involved in the initial patients' treatment. The time interval between initial symptoms and neurosurgical admission varied enormously. Statistically, higher Hunt & Hess score did not lead to an earlier diagnosis (p = 0.56) nor did localisation of the aneurysm (p = 0.75). Lower Fisher score was led to delayed diagnosis (p = 0.02). Delay of diagnosis was not significantly associated with the outcome (p = 0.08) whereas Hunt & Hess grade on admission was a strong predictor for bad outcome (p = 0.00001) as was cerebral vasospasm on the first angiogram (p < 0.05).
A straightforward diagnosis of SAH despite diffuse and unspecific symptoms is crucial for the successful treatment of these patients, especially with high grade SAH.
患有蛛网膜下腔出血(SAH)的患者可能会出现多种症状。本研究旨在评估误诊的范围,并分析正确诊断延迟对临床结果的意义。
本研究的数据是从 2003 年至 2013 年前瞻性收集的。最初治疗医生诊断为不同于动脉瘤性 SAH 的疾病的患者,且在症状开始后至少 24 小时才转入我院,符合纳入标准。我们分析了最初被确定为 SAH 以外的各种诊断,以及提供这些诊断的医疗专业。
共有 704 例患者接受了急性 SAH 治疗。在 76 例患者(13.7%)中匹配了纳入标准。11 个专科参与了最初患者的治疗。初始症状和神经外科入院之间的时间间隔差异很大。统计分析表明,较高的 Hunt & Hess 评分并未导致更早的诊断(p=0.56),也未导致动脉瘤的定位(p=0.75)。较低的 Fisher 评分导致诊断延迟(p=0.02)。诊断延迟与结果无显著相关性(p=0.08),而入院时的 Hunt & Hess 分级是不良结果的强烈预测因素(p=0.00001),首次血管造影时的脑血管痉挛也是不良结果的预测因素(p<0.05)。
尽管症状广泛且不特异,但明确诊断 SAH 对这些患者的成功治疗至关重要,尤其是对于高分级的 SAH。